Search Results - NGSMEDICARE

Posting Date: 07/18/2018

Medical Policy Contact Information

Medical Policy Contact Information Please Note: General inquiries related to Medicare coverage policies, including clinical issues, drugs, radiopharmaceuticals, local and national coverage determinations, billing and reimbursement must be [...]

Posting Date: 07/21/2023

Tip Sheet for Medicare Providers on First Level of Appeals (Redeterminations)

Tip Sheet for Medicare Providers on First Level of Appeals (Redeterminations) If you disagree with Medicare’s claim determination, you may Appeal. However, please follow these important tips before you submit a first level of appeal [...]

Posting Date: 07/21/2023

Tip Sheet for Medicare Providers on First Level of Appeals (Redeterminations)

Tip Sheet for Medicare Providers on First Level of Appeals (Redeterminations) If you disagree with Medicare’s claim determination, you may Appeal. However, please follow these important tips before you submit a first level of appeal [...]

Posting Date: 07/21/2023

Tip Sheet for Medicare Providers on First Level of Appeals (Redeterminations)

Tip Sheet for Medicare Providers on First Level of Appeals (Redeterminations) If you disagree with Medicare’s claim determination, you may Appeal. However, please follow these important tips before you submit a first level of appeal [...]

Posting Date: 08/12/2024

Medicare Bad Debts

Table of Contents Review Medicare Bad Debt Listing Identifying Non-Allowable Fee Schedule Services Fee Schedules Included in Bad Debt Policy Medicare Bad Debts Related Content [Return to Top] Review Medicare Bad Debt Listing [...]

Posting Date: 10/05/2023

Billing and Coding: Bortezomib

Billing and Coding: Bortezomib drug A52371 https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=52371 J9041, J9046, J9048, J9049, J9051

Posting Date: 08/09/2024

Monoclonal Antibodies in Treatment of Alzheimer’s Disease - Medicare Advantage Plan Responsibility

Monoclonal Antibodies in Treatment of Alzheimer’s Disease - Medicare Advantage Plan Responsibility NCD 200.3 was issued by CMS in April,2022 and outlines Medicare coverage policy for monoclonal antibodies that target amyloid (or plaque) for [...]

Posting Date: 08/10/2024

HETS EDI Enrollment Form User Guide

The HETS EDI Enrollment Form allows providers to attest their relationship with a 3rd party entity to exchange the ANSI X12 270/271 Beneficiary Eligibility transaction on their behalf. Table of Contents Step 1 – Authorization [...]